Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues
Net product revenues	$ 117,870	$ 141,581	$ 357,721	$ 322,052
License revenues	45,010	173,798	3,144,698	610,732
Total revenues	162,880	315,379	3,502,419	932,784
Cost of revenues
License revenue sharing	289,463		289,463
Cost of product revenues	28,521	36,684	101,079	97,380
Total cost of revenues	317,984	36,684	390,542	97,380
Gross margin	(155,104)	278,695	3,111,877	835,404
Patent Monetization expenses	10,074	2,143,616	1,734,245	4,142,138
Research and development expenses	182,335	197,547	562,383	551,888
General, administrative and selling expenses	295,916	321,925	960,271	822,382
Continuing operating loss	(643,429)	(2,384,393)	(145,022)	(4,681,004)
Interest income (expense), net	3,228	(19,350)	5,855	(37,411)
Loss from continuing operations before provision for income taxes	(640,201)	(2,403,743)	(139,167)	(4,718,415)
(Benefit) provision for income taxes	(38,710)	34,120	9,316	119,958
Loss from continuing operations	(601,491)	(2,437,863)	(148,483)	(4,838,373)
(Loss) income from discontinued operations		(60,796)		575,895
Net loss	$ (601,491)	$ (2,498,659)	$ (148,483)	$ (4,262,478)
Basic and diluted weighted average shares	64,914,935	64,134,024	64,741,959	63,860,211
Basic and diluted net loss per share from continuing operations	$ (0.01)	$ (0.04)	$ 0.00	$ (0.08)
Basic and diluted net (loss) income per share from discontinuing operations	0.00	0.00	0.00	0.01
Basic and diluted net loss per share	$ (0.01)	$ (0.04)	$ 0.00	$ (0.07)